GOLDMAN SACHS GROUP INC - ACRIVON THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

ACRIVON THERAPEUTICS INC's ticker is and the CUSIP is 004890109. A total of 19 filers reported holding ACRIVON THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Links
Filings
Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACRIVON THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$174,081
-61.1%
13,718
-64.6%
0.00%–
Q4 2022$446,976–38,800–0.00%–
 Download
Other shareholders
ACRIVON THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
EXCHANGE TRADED CONCEPTS, LLC 13,289$65,3820.00%
View complete list of ACRIVON THERAPEUTICS INC shareholders